Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In this report we describe two mutations in the human PAX3 gene causing WS type I in two families.
|
8799378 |
1996 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In this report, we describe two mutations in the human PAX3 gene that cause WS type I.
|
8019556 |
1994 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In this study, we reported a rare Waardenburg syndrome simplex family in which a pair of WS parents gave birth to a child with double heterozygous mutations of MITF and PAX3.
|
22320238 |
2013 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Known mutations in PAX3 are etiologically associated with Waardenburg syndrome and syndromic neural tube defects (NTDs).
|
17149730 |
2007 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Many genes have been linked to WS, including PAX3, MITF, SNAI2, EDNRB, EDN3, and SOX10, and many additional genes have been associated with disorders with phenotypic overlap with WS.
|
25932447 |
2015 |
Waardenburg Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular Etiology of Hereditary Single-Side Deafness: Its Association With Pigmentary Disorders and Waardenburg Syndrome.
|
26512583 |
2015 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation in PAX3 causes Waardenburg syndrome, and craniofacial-deafness-hand syndrome.
|
18627422 |
2008 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation screening of six WS-associated genes detected PAX3 mutations in 6 (86%) of the 7 WS1 probands.
|
27759048 |
2016 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Mutation screening of six WS-associated genes detected PAX3 mutations in 6 (86%) of the 7 WS1 probands.
|
27759048 |
2016 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PAX3 were associated with Waardenburg syndrome with strabismus.
|
28861346 |
2017 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in Pax-3 cause Waardenburg syndrome (WS) in humans and the mouse Splotch (Sp) phenotype.
|
9302254 |
1997 |
Waardenburg Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature.
|
8533800 |
1995 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I).
|
8447316 |
1993 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our analyses suggest that genetic background in combination with certain PAX3 alleles may be important factors in the aetiology of deafness in WS.
|
9192262 |
1997 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Our findings suggest that PAX3 WS mutants interfere with the normal functions of PAX3 in a dominant negative manner, which is important to the understanding of the pathogenesis of Waardenburg syndrome.
|
26149688 |
2015 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our results expand the spectrum of PAX3 mutations and may have implications for the genetic counseling of WS in Iran.
|
26275939 |
2015 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Pax3 functions at a nodal point in melanocyte stem cell differentiation.
|
15729346 |
2005 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.
|
18983540 |
2008 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Point mutations in PAX3 have been identified in more than 90% of affected individuals with WS Type 1/WS Type 3.
|
17627390 |
2007 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
Point mutations in PAX3 have been identified in more than 90% of affected individuals with WS Type 1/WS Type 3.
|
17627390 |
2007 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Presence of dystopia canthorum is indicative of WS type 1 and results from defects in the PAX3 gene, whereas normally located medial canthi is characteristic of type 2 WS (WS2) and is associated with defects in the microphthalmia-associated transcription factor (MIFT) gene.
|
9584079 |
1998 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Rare variants in PAX3 are known to cause Waardenburg syndrome, which involves deafness, pigmentary abnormalities, and facial characteristics including a broad nasal bridge.
|
22341974 |
2012 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Recently, we identified some novel WS-associated mutations in PAX3 and SOX10 in a cohort of Chinese WS patients.
|
21965087 |
2012 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?
|
18553554 |
2008 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Study of 14 WS type 1 (WS1) families yielded a maximum lod score of 27.81 at PAX3, theta f = 0.010, theta = 0.007 assuming homogeneity.
|
7590754 |
1995 |